Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation

NCT00377962 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

282

Enrollment

INDUSTRY

Sponsor class

Conditions

Disorder Related to Cardiac Transplantation

Interventions

DRUG: Everolimus
DRUG: Mycophenolic acid (MPA)/azathioprine (AZA)
DRUG: Calcineurin inhibitors (CNI)
DRUG: Steroids

Sponsor

Novartis Pharmaceuticals